SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001551986-20-000118
Filing Date
2020-05-04
Accepted
2020-05-04 18:58:24
Documents
2
Period of Report
2020-04-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_158863308188112.html 3  
1 FORM 3 wf-form3_158863308188112.xml 3 3593
2 POA JTEMPERATO 2020 ex-24.htm EX-24 3321
  Complete submission text file 0001551986-20-000118.txt   8524
Mailing Address 8480 HONEYCUTT ROAD SUITE 120 RALEIGH NC 27615
Business Address 8480 HONEYCUTT ROAD SUITE 120 RALEIGH NC 27615 919-275-1933
INNOVATE BIOPHARMACEUTICALS, INC. (Issuer) CIK: 0001551986 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MELINTA THERAPEUTICS,INC. 300 GEORGE STREET, SUITE 301 NEW HAVEN CT 06511
Business Address
Temperato John (Reporting) CIK: 0001722407 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37797 | Film No.: 20846365